Patient-Reported Outcomes in a Phase III Study of Everolimus Versus Placebo in Patients with Metastatic Carcinoma of the Kidney That Has Progressed on Vascular Endothelial Growth F...

Por Beaumont, Jennifer L., Butt, Zeeshan, Baladi, Jeanfrancois, Motzer, Robert J., Haas, Tomas, Hollaender, Norbert, Kay, Andrea, Cella, David
Publicado em 2011

Dynamic tumor modeling of the dose–response relationship for everolimus in metastatic renal cell carcinoma using data from the phase 3 RECORD-1 trial

Por Stein, Andrew, Wang, Wenping, Carter, Alison A, Chiparus, Ovidiu, Hollaender, Norbert, Kim, Hyewon, Motzer, Robert J, Sarr, Celine
Publicado em 2012

Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study

Por Taher, Ali T., Karakas, Zeynep, Cassinerio, Elena, Siritanaratkul, Noppadol, Kattamis, Antonis, Maggio, Aurelio, Rivella, Stefano, Hollaender, Norbert, Mahuzier, Bruyère, Gadbaw, Brian, Aydinok, Yesim
Publicado no Blood (2018)